Three-dimensional structure of a Nanobody® (modeled on the VHH with pdb-code 1U0Q, Cambillau et al). The target molecule is recognized by the surface formed by three hypervariable regions located at the top of the molecule (in green, cyan and blue). Hallmarks, amino acid residues that further differentiate a camelid VHH from a human VH, can be located at different positions within the framework regions, and here are coloured red, pink and magenta.

Home News room Press releases 2005
Press releases

2005

31/08/2005
ABLYNX SUCCESSFULL IN MAINTAINING KEY CLAIMS AFTER NANOBODY™ PATENT CHALLENGE

18/08/2005
ABLYNX APPOINTS HENNIE HOOGENBOOM AS CHIEF SCIENTIFIC OFFICER

01/08/2005
SCIENTIFIC AMERICAN REVIEWS THE POTENTIAL OF ABLYNX'S NANOBODIES AS DRUGS
> DIRECT LINK TO ARTICLE

26/05/2005
ABLYNX AND THE NATIONAL RESEARCH COUNCIL CANADA SIGN COLLABORATIVE DEAL TO DEVELOP NANOBODIES™ FOR CNS DISORDERS

Press releases

News archive

Email alerts

If you would like to receive updates on the company news, please
click here